Farms.com Home   News

US Ag Trade Report 2022: Balancing Wins and Losses in a Changing Landscape

The 2022 ag trade report highlights both positive and negative developments in the US agricultural industry. Despite challenges posed by the COVID-19 pandemic and ongoing trade tensions, there were several notable achievements in 2022.

Among the achievements were increased exports of pork, beef, and poultry to China, as well as increased sales of soybeans to Southeast Asia. Additionally, the US reached a trade agreement with Kenya, providing new opportunities for American farmers to sell their products in the East African nation.

However, the report also details areas where the US agricultural industry faces challenges. The ongoing trade dispute with China has resulted in reduced exports of soybeans and other products to the country, while retaliatory tariffs imposed by the EU and other trading partners have impacted sales of American products.

Additionally, supply chain disruptions and labor shortages caused by the pandemic have led to higher costs and reduced efficiency for farmers and processors.

Moving forward, the report emphasizes the importance of continued trade negotiations and efforts to reduce barriers to trade. It also calls for investments in infrastructure and innovation to help farmers remain competitive in an increasingly global market.

While the US agricultural industry faces both opportunities and challenges, the report suggests that with the right policies and support, it can continue to thrive in the years to come.


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.